VANCOUVER, Nov. 29 /CNW/ - Protox(TM) Therapeutics Inc. (TSX-V:PRX)
announced today that it has successfully completed its previously announced
unit offering with the issue of 18,349,500 units at a price of $0.50 per unit
for total gross proceeds of $9,174,750. Each unit comprises one common share
and one-half of one common share purchase warrant. Each whole warrant entitles
the holder to purchase one common share of Protox at a price of $0.65 on or
before 29 November 2008.
